検索結果 - Federico Simonetti
- 検索結果 1 - 2 結果 / 2
-
1
Ruxolitinib Rapidly Reduces Acute Respiratory Distress Syndrome in COVID-19 Disease. Analysis of Data Collection From RESPIRE Protocol 著者: Enrico Capochiani, Bruno Frediani, Giorgio Iervasi, Aldo Paolicchi, Spartaco Sani, P Roncucci, Annarosa Cuccaro, Federico Franchi, Federico Simonetti, Davide Carrara, Ilaria Bertaggia, Daniela Nasso, Rossella Riccioni, Sabino Scolletta, Serafina Valente, Edoardo Conticini, Alessandro Gozzetti, Monica Bocchia
出版事項 2020Artigo -
2
INCB84344-201: Ponatinib and steroids in frontline therapy for unfit patients with Ph+ acute lymphoblastic leukemia 著者: Giovanni Martinelli, Cristina Papayannidis, Alfonso Piciocchi, Valentina Robustelli, Simona Soverini, Carolina Terragna, Giovanni Marconi, Roberto M. Lemoli, Fabio Guolo, Antonella Fornaro, Monia Lunghi, Paolo de Fabritiis, Anna Candoni, Carmine Selleri, Federico Simonetti, Monica Bocchia, Antonella Vitale, Luca Frison, Alessandra Tedeschi, Antonio Cuneo, Massimiliano Bonifacio, Maria Paola Martelli, Stefano D’Ardìa, Silvia Trappolini, Patrizia Tosi, Piero Galieni, Francesco Fabbiano, Maria Chiara Abbenante, Muriel Granier, Zhaoyin Zhu, Mingyue Wang, Chiara Sartor, Stefania Paolini, Michèle Cavo, Robin Foà, Paola Fazi, Marco Vignetti, Michele Baccarani
出版事項 2021Artigo
関連主題
Internal medicine
Medicine
Acute lymphocytic leukemia
Acute respiratory distress
Adverse effect
Alternative medicine
Bone marrow
Chemotherapy
Clinical endpoint
Clinical trial
Coronavirus
Coronavirus disease 2019 (COVID-19)
Dasatinib
Disease
Gastroenterology
Imatinib
Immunology
Infectious disease (medical specialty)
Intensive care medicine
Leukemia
Lung
Lymphoblastic Leukemia
Myelofibrosis
Myeloid leukemia
Pathology
Ponatinib
Prednisone
Protocol (science)
Rash
Ruxolitinib